Besides transforming the immunosuppressive tumor microenvironment into a pro-inflammatory one via inhibiting PD-L1, Zhang et al. have demonstrated that miR-200-3p can suppress ANLN in TNBC cells. Here, ANLN is linked to neoplasm.